CELL INTELLIGENCE · 肿瘤细胞治疗研究

NSCLC 精准免疫肿瘤学：整合 ADC、治疗性疫苗与过继性细胞治疗用于下一代全身治疗

Precision immuno-oncology in NSCLC: integrating ADCs, therapeutic vaccines, and adoptive cell therapies for next-generation systemic treatment.

CpG 1018 通过增强 CD8+ T 细胞反应来增强 mRNA 疫苗诱导的抗肿瘤免疫

CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses.

晚期转移性黑色素瘤治疗新标准：免疫治疗与 BRAF 靶向治疗作为新兴范式

New Standards in the Treatment of Advanced Metastatic Melanoma: Immunotherapy and BRAF-Targeted Therapies as Emerging Paradigms.

绘制基于纳米技术的肝细胞癌免疫治疗研究全景

Mapping the research landscape of nanotechnology based immunotherapy for hepatocellular carcinoma.

基于纳米技术的免疫治疗领域已从基础纳米颗粒开发（2005–2009）发展到免疫微环境调控（2010–2018），如今迈入基于 mRNA 的精准免疫治疗（2019–2024）。未来的努力可能优先考虑整合代谢调控和 AI 优化递送的综合纳米免疫治疗。

针对细胞治疗中肿瘤抗原逃逸的创新基因工程策略

Innovative gene engineering strategies to address tumor antigen escape in cell therapy.

泛素特异性蛋白酶 6 mRNA 脂质纳米颗粒在尤文肉瘤中激发抗肿瘤免疫并抑制肿瘤发生

Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma.

用于体内工程化肿瘤靶向 NK 细胞的嵌合抗原细胞毒性受体

Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells.

NKG7 是提高抗肿瘤细胞毒性和癌症免疫治疗的 T 细胞内在治疗靶点

NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.